Home » Nanosphere Submits 510(k) for Acute Coronary Syndromes Assay
Nanosphere Submits 510(k) for Acute Coronary Syndromes Assay
Nanosphere, Inc. … announced it submitted a 510(k) application to
the FDA for its cardiac troponin I test that the company believes will provide early and sensitive diagnosis of myocardial infarction and risk stratification
for acute coronary syndromes.
CNNMoney
CNNMoney
Upcoming Events
-
07May
-
14May
-
30May